Please login to the form below

Not currently logged in
Email:
Password:

Nikon expands into healthcare and buys retinal tech firm

Japanese camera and technology company spends big on Scotland’s Optos

Eye test Nikon Corporation will pay £259m to obtain full control of Scottish eye specialist firm Optos.

The Fife-based company develops eye testing machines which can detect high blood pressure and a number of cancers. 

Nikon is publically best known for its cameras but as with a number of technology firms, such as Samsung, IBM, Apple and Microsoft, the Japanese company is looking to move into the medical sector. Nikon said in a statement that this was “important for its long-term growth”.

Kazuo Ushida, the president of Nikon, said: “I am pleased to announce this strategically important transaction for Optos and Nikon. I am confident that an Optos/Nikon combination would create a world-class 'retina' player and would significantly benefit our respective stakeholders.

“Together, we will pursue various collaboration opportunities and further expand the medical business in the future.”

Optos' chairman, Dr Peter Fellner, added: “Following the transaction, Optos will become a key part of Nikon's future strategy to develop a global medical business and will continue to provide its market-leading solutions to the patients we serve.

“We are therefore pleased to recommend this acquisition to our shareholders.”

In November last year, Optos reported a rise in sales and profits after installing a record number of new products, with revenue increasing by 7% to $170.6m (£109m) in the year to the end of September. Pre-tax profit tax doubled to $18.5m.

Article by
Ben Adams

5th March 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
Patient diversity in clinical trials
The pursuit of patient diversity in clinical trials
When all-inclusive isn’t an option, it’s an obligation...
Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...